Glutathione is a tripeptide i.e
Macrophotographs were taken at baseline and after 6 months, and 2 independent evaluators rated them using the Jaeschke rating of clinical change
Boretto M, Maenhoudt N, Luo X, Hennes A, Boeckx B, Bui B, Heremans R, Perneel L, Kobayashi H, Van Zundert I, Brems H, Cox B, Ferrante M, Uji IH, Koh KP, DHooghe T, Vanhie A, Vergote I, Meuleman C, Tomassetti C, Lambrechts D, Vriens J, Timmerman D, Vankelecom H (2019) Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening
Be cautious of exaggerated claimsno glutathione supplement is currently approved by the MHRA for treating fatty liver disease, and any product making specific disease treatment claims may be in breach of UK advertising regulations